The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment
Clinical trial NCT04358224 · COMPLETED
Trial details
- NCT number
- NCT04358224
- Sponsor
- Jonathan A. Bernstein, MD
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-01
- Primary completion
- 2022-11-18
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.